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Purpose:  Under different culture conditions, periodontal ligament (PDL) stem cells are capable of differentiating into cement-
oblast-like cells, adipocytes, and collagen-forming cells. Several previous studies reported that because of the stem cells in the 
PDL, the PDL have a regenerative capacity which, when appropriately triggered, participates in restoring connective tissues 
and mineralized tissues. Therefore, this study analyzed the genes involved in mineralization during differentiation of human 
PDL (hPDL) cells, and searched for candidate genes possibly associated with the mineralization of hPDL cells.
Methods: To analyze the gene expression pattern of hPDL cells during differentiation, the hPDL cells were cultured in two 
conditions, with or without osteogenic cocktails (β-glycerophosphate, ascorbic acid and dexamethasone), and a DNA microar-
ray analysis of the cells cultured on days 7 and 14 was performed. Reverse transcription-polymerase chain reaction was per-
formed to validate the DNA microarray data.
Results: The up-regulated genes on day 7 by hPDL cells cultured in osteogenic medium were thought to be associated with 
calcium/iron/metal ion binding or homeostasis (PDE1A, HFE and PCDH9) and cell viability (PCDH9), and the down-regulated 
genes were thought to be associated with proliferation (PHGDH and PSAT1). Also, the up-regulated genes on day 14 by hPDL 
cells cultured in osteogenic medium were thought to be associated with apoptosis, angiogenesis (ANGPTL4 and FOXO1A), and 
adipogenesis (ANGPTL4 and SEC14L2), and the down-regulated genes were thought to be associated with cell migration (SL-
C16A4).
Conclusions: This study suggests that when appropriately triggered, the stem cells in the hPDL differentiate into osteoblasts/
cementoblasts, and the genes related to calcium binding (PDE1A and PCDH9), which were strongly expressed at the stage of 
matrix maturation, may be associated with differentiation of the hPDL cells into osteoblasts/cementoblasts. 
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INTRODUCTION
The periodontal ligament (PDL) is a fibrous connective tis-
sue that surrounds and supports the tooth, and is located be-
tween the cementum of the root and the inner wall of the al-
veolar bone socket. It plays a crucial role in the maintenance 
and regeneration of periodontal tissue. 
PDL contains a heterogeneous cell population at various 
stages of differentiation and lineage responsibility. Previous 
studies have suggested that PDL cells can form mineralized 
nodules in vitro and express bone-related proteins, such as 
alkaline phosphatase, bone sialoprotein and osteocalcin [1-4]. 
Recently, Seo et al. [5] reported that human PDL (hPDL) cells 
contain stem cells with a high proliferative capacity, self-re-
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newal properties, multilineage differentiation potential and 
the capability of forming cementum/periodontal ligament-
like tissue in vivo. Also, under different culture conditions, 
they suggested that isolated PDL stem cells are capable of 
differentiating into cementoblast-like cells, adipocytes, and 
collagen-forming cells. Particularly, cementoblastic/osteo-
blastic differentiation for the formation of new cementum or 
bone is very important to regeneration of the periodontium 
[6,7]. Commonly, osteoblasts form bone-like mineralized 
nodules in culture by undergoing three stages of differentia-
tion: proliferation, extracellular matrix maturation and min-
eralization [8]. However, the exact molecular mechanism con-
trolling the differentiation mechanism of progenitors in hPDL 
cells remain largely unknown. 
The microarray has been successful in identifying differen-
tiation stage-specific gene expression. Kulterer et al. [8] iden-
tified three novel candidate genes (ID4, CRYAB and SORT1) 
using microarray analysis of mesenchymal stem cell during 
osteogenic differentiation. Yamada et al. [9] reported that 
PLAP-1 regulated PDL cell mineralization negatively using a 
DNA microarray. Using a microarray, Lallier and Spencer [10] 
reported that PDL cells in culture are regulated by several 
factors that differentially stimulate a mineralized fate, a non-
mineralized fate, or the propagation of a more naive pheno-
type. In a previous study using a cDNA microarray, Shin et al. 
[11] reported that at the stage of mineralization of hPDL cells, 
apoptosis-inducing agents were up-regulated, and anti-apop-
tosis activators were down-regulated. Even though there are 
many studies about the differentiation and mineralization of 
PDL, the analysis of the gene expressed in each stage during 
differentiation are not well understood and remains an ac-
tive area of investigation [9-11]. Thus, the analysis of genes 
related to each stage of differentiation is very important.
Therefore, in the present study, using a culture system that 
facilitates the formations of mineralized nodules in hPDL 
cells, this study analyzed gene-expression profiles on days 7 
and 14 of culture using a DNA microarray and sought candi-
date genes possibly associated with mineralization in an es-
tablished line of hPDL cells characterized by the ability to 
differentiate into osteoblastic/cementoblastic lineages. 
MATERIALS AND METHODS
hPDL cell isolation and culture
After receiving patient written consent, PDL tissues were 
obtained from the PDL of premolar teeth extracted during 
orthodontic treatment. Premolars (n=5) were collected from 
5 female individuals aged 10 to 20 years, at Kyungpook Na-
tional University Dental Hospital, Department of Periodon-
tology.
The primary culture of the PDL cells was prepared using an 
explant technique according to a previous study [11]. The PDL 
cells were incubated in culture medium (Dulbecco’s modified 
eagle medium [DMEM] with 10% fetal bovine serum [FBS], 
100 U/mL penicillin and 100 µg/mL streptomycin) in a hu-
midified atmosphere of 95% air. The medium was changed 
three times a week, and the hPDL cells used in this study 
were at 2 to 5 passages.
Mineralized nodule formation
Mineralized nodule formation was evaluated by Dahl’s 
method for calcium [12]. The hPDL cells were placed in a 24-
well plate at a density of 2×10
4 cells/well and cultured in os-
teogenic medium (DMEM with 10% FBS, 50 µg/mL ascorbic 
acid, 10 mM β-glycerophospahte and 100 nM dexametha-
sone) or non-osteogenic medium (DMEM with 10% FBS) for 
2 weeks. The cells were fixed in 2% paraformaldehyde neu-
tral buffer solution and then stained with alizarin red S.
DNA microarray analysis 
DNA microarray technologies were used to identify the 
differentiation-related genes of the hPDL cells. Five inde-
pendently isolated hPDL cell samples were placed in a 6-well 
plate at a density of 1×10
5 cells/well. Culture plates were di-
vided into 2 groups and cells were cultured in 1) osteogenic 
medium or 2) non-osteogenic medium for 7 and 14 days. On 
day 7 and 14, the total RNA was isolated from cultured cells 
using an RNeasy Mini Kit (Qiagen GmbH, Hilden, Germa-
ny). The purity and integrity of the total RNA were verified 
using a UV spectrometer (Beckman DU530, Harlow Scientif-
ic, Arlington, MA, USA), respectively. Total RNA samples from 
different individuals were pooled and then the next experi-
ments were carried out. Probe synthesis from total RNA sam-
ples, hybridization, detection, and scanning were performed 
according to standard protocols from Affymetrix Inc. (Santa 
Clara, CA, USA). Samples were analyzed by the use of the Af-
fymetrix HG-U133 Plus 2.0 genechip, which contains 47,000 
transcripts. 
Data analysis and statistics
Expression profiles were analyzed using GeneChip Operat-
ing Software (GCOS, Affymetrix Inc.) and other programs. 
The Affymetrix software was used to identify changes in ex-
pression levels between the osteogenic medium group and 
non-osteogenic medium group using standard protocols 
recommended by Affymetrix. All genes with normalized data 
values >1.0 fold higher (up/down-regulation) than in the oth-
er groups were selected. Next, the genes with more than a 
3-fold change and a signal value of 100 were filtered. Gene 
function analysis was performed by using the gene ontology Journal of Periodontal
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mining tool of NetAffx, which is based on the Gene Ontolo-
gy database (http://www.geneontology.org). Specification of 
the many gene annotations was also supplemented by fur-
ther online database searches.
RT-PCR
To validate the DNA microrarray data, some genes expressed 
at each function’s groups on indicated days were selected, 
and their expression was measured by reverse transcription-
polymerase chain reaction (RT-PCR). 
The DNA was synthesized from the same total RNA as used 
for the DNA microarray. The oligonucleotide RT-PCR prim-
ers listed in Table 1 were purchased from Bioneer Corpora-
tion (Daegeon, Korea). Amplifications were performed in a 
PTC-2000 thermal cycler (MJ Research, Waltham, MA, USA) 
for 27 to 30 cycles after an initial 30 seconds denaturation at 
94°C, annealed for 30 seconds at 56°C, and extended for 30 
seconds at 72°C in all primers. The amplification reaction 
products were resolved on 1% agarose/Tris-acetate-EDTA 
gels (Combrex BioScience, Rockland, ME, USA), electropho-
resed at 100 mV, and visualized by ethidium-bromide stain-
ing. 
RESULTS
Evaluation of mineralized nodule formation 
The degree of mineralization in the hPDL cells cultured for 
2 weeks by alizarin red S stain was assessed (Fig. 1). The hPDL 
cells cultured in non-osteogenic medium were not observed 
to have a mineralized nodule. However, the hPDL cells cul-
tured in osteogenic medium were observed to have a miner-
alized nodule on day 14, but on day 7, a mineralized nodule 
was not observed in the osteogenic medium. 
DNA microarray analysis
The five hPDL cell samples were cultured from each of the 
two different culture media from each day 7 and 14 and total 
RNA was isolated for analysis on the DNA microarray. An ar-
ray of differentiation-related genes in the hPDL cells under-
going osteogenic differentiation was analyzed. 
Among more than 47,000 genes analyzed, 111 genes were 
up-regulated more than 3-fold on day 7 in cells that were cul-
tured in osteogenic medium, and 19 genes were down-regu-
lated more than 3-fold in the osteogenic medium. On day 14, 
77 genes were up-regulated, and 19 genes were down-regu-
lated in the osteogenic medium. 
Table 1.  Primer sequences used in reverse transcription-poly-
merase chain reaction.
GenBank 
accession number
Gene Sequence
Products 
size (bp)
NM_002046 GAPDH F 5-TCCACCACCCTGTTGCTGTA-3 
R 5-ACCACAGTCCATGCCATCAC-3
450
NM_001003683 PDE1A  F 5-TTGTGATCGGAAGTCAACCA-3 
R 5-GGGGAATAGGACCCATCACT-3
249
NM_030643 APOL4 F 5-ACTAGCGATGAAGCCTGGAA-3 
R 5-AGCCTCTGTGGACCTTTTCA-3
250
NM_001003704 MTP18  F 5-CCCAGCTCCTCCTGATCATA-3 
R 5-GCTTCTGTCCAGCTCAAACC-3
151
NM_018659 CYTL1 F 5-ACTGTGTGCTGGACAAGCTG-3 
R 5-CATTGCAGTCATCCAACAGG-3
156
NM_000600  IL6 F 5-TACCCCCAGGAGAAGATTCC-3 
R 5-TTTTCTGCCAGTGCCTCTTT-3
175
NM_006623   PHGDH F 5-GGCTCAATGGAGCTGTCTTC-3 
R 5-TTCAGTCACATGCTGCTTCC-3
242
NM_021154 PSAT1 F 5-AGAATCTTGTGCGGGAATTG-3 
R 5-CCCAAGTTTAGGGTGAACGA-3
218
NM_014333 IGSF4 F 5-CCCAGCCTGTGATGGTAACT-3 
R 5-TGATCGAGCCTTCTTCACCT-3
207
NM_006393 NEBL F 5-GATGGACAGGAGACCTGGAA-3 
R 5-ATCGTACATGGCTCGGTAGG-3
158
NM_001999 FBN2 F 5-CAACACCGTGGGAAGCTATT-3 
R 5-CCTCTGACAGGACAGGCTTC-3
222
NM_003182 TAC1 F 5-GTACGACAGCGACCAGATCA-3 
R 5-AGCCTTTAACAGGGCCACTT-3
157
NM_000609 CXCL12 F 5-TCAGCCTGAGCTACAGATGC-3 
R 5-CTTTAGCTTCGGGTCAATGC-3
161
NM_004696 SLC16A4 F 5-TGGGATGGGACTGACTTTTC-3 
R 5-CCATGTGCAGACAAACTGCT-3
198
NM_000693 ALDH1A3 F 5-TCTCGACAAAGCCCTGAAGT-3 
R 5-TATTCGGCCAAAGCGTATTC-3
150
Denaturing, annealing and elongation conditions were 94°C 30 seconds, 56°C 30 
seconds and 72°C 30 seconds, respectively. The total number of cycles was 27 to 30. 
F: forward, R: reverse.
Figure 1.  Alizarin red S staining of the mineralized nodules cul-
tured for 7 days (A) and 14 days (B) with osteogenic medium and 
non-osteogenic medium. Circular photographs show human peri-
odontal ligament cells in the culture plate (24 wells). On day 7, min-
eralized nodules were not observed at all, but on day 14, mineralized 
nodules were only observed in the osteogenic group.
A
B
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Verification of DNA microarray data
To validate the DNA microarray data, some genes expressed 
in each function’s groups on the indicated days were select-
ed, and their expression was measured by RT-PCR (Table 1). 
Twelve out of 14 genes were comparable with the DNA mi-
croarray data, suggesting that our microarray experiment 
was properly performed. TAC1 were expressed not signifi-
cantly, and NEBL were not expressed (Fig. 2). Except for 2 
genes, all genes were comparable with the DNA microarray 
data. A large part of the selected genes on indicated days were 
also expressed in other conditions. 
Identification and functional classification of expressed 
genes
By comparing the lists of differentially expressed genes from 
each of the two groups, a group of functionally expressed 
genes (Tables 2-5) was classified. Gene function analysis was 
carried out by searching the National Center for Biotechnol-
ogy Information database. The classified genes were related 
to signal transduction, transport, metabolism, cell adhesion, 
apoptosis, development, cell-cell signaling and angiogenesis 
during differentiation of hPDL cells.
Genes related to signal transduction
On day 7, the up-regulated genes related to signal transduc-
tion were PDE1A, MYO10, APOB, and so on, and down-regu-
lated genes were CYTL1 and IL6. On day 14, the up-regulated 
genes were ANGPTL4, EPHA3, RASL10B, etc., and the down-
regulated genes were CXCL12, CCL8 and VLDLR. The genes 
up-regulated on both days were LEP, RAC3, and RASL11B, 
and those down-regulated both days were MX1 and WISP2. 
Notably, up- and down-regulated genes PDE1A, APOB, AL-
CAM, PSCD4, CYTL1, and IL6 were more strongly expressed 
on day 7 than on day 14, while ANGPTL4, EPHA3, RAB12, 
CXCL12, CCL8, and VLDLR were more strongly expressed on 
day 14 than on day 7.
Genes related to transport
On day 7, the up-regulated genes related to transport were 
APOL4, APOB, CLCN5, etc., and the down-regulated genes 
were PHGDH and SLC7A5. On day 14, the up-regulated genes 
were NEBL, SEC14L2, CLIC6, etc., and the down-regulated 
genes were SLC16A4, CCL8, and VLDLR. The genes up-regu-
lated on both days were FABP4, STEAP4, APOD, etc., and the 
one down-regulated on both days was NPTX1. Interestingly, 
the up and down regulated genes APOB, CLCN5, HFE, SL-
C24A3, KCNK6, PHGDH and SLC7A5 were more strongly ex-
pressed on day 7 than on day 14, while NEBL, SEC14L2, CLIC6, 
RAB12, SLC16A4, CCL8, and VLDLR were more strongly ex-
pressed on day 14 than on day 7.
Genes related to metabolism
On day 7, the up-regulated genes related to metabolism were 
APOL4, EHHADH, APOB, etc., and the down-regulated genes 
were PSAT1, PHGDH, SLC7A5, and ASNS. On day 14, the up-
regulated genes were ANGPTL4, PDK4, GNLY, etc., and the 
down-regulated genes were ALDH1A3 and VLDLR. The genes 
up-regulated on both days were CORIN, LEP, GGTLA1, etc., 
and the one down-regulated on both days was PTGS2. Nota-
bly, up- and down-regulated genes APOB, PDK3, CPM, MVK, 
PSAT1, PHGDH, SLC7A5, and ASNS were more strongly ex-
pressed on day 7 than on day 14, and ANGPTL4, PDK4, GNLY, 
ALDH1A3, while VLDLR were more strongly expressed on day 
14 than on day 7. 
Genes related to cell adhesion
On day 7, the up-regulated genes related to cell adhesion 
were PCDH9, NRP2, and ALCAM, and the down-regulated 
gene was IGSF4. On day 14, the up-regulated genes were FBN2 
GAPDH
PDE1A
APOL4
MTP18
CYTL1
PHGDH
PSAT1
IGSF4
IL6
GAPDH
NEBL
FBN2
TAC1
CXCL12
SLC16A4
ALDHA3
Day 7
-               +
Day 14
-               +
Figure 2.  Expression on day 7 and 14 of selected genes by human 
periodontal ligament (hPDL) cells cultured in osteogenic or non-os-
teogeneic medium. The hPDL cells were cultured for 7 days in an 
osteogenic medium (+) or non-osteogenic medium (-). The 12 out of 
14 genes were comparable with DNA microarray data. The expres-
sion patterns of tachykinin, precursor 1 were not significant, and 
nebulette were not expressed. Similar results were obtained in 2 
separate experiments and representative data are shown. GAPDH: 
glyceraldehyde-3-phosphate dehydrogenase, PDE1A: phosphodies-
terase 1A, calmodulin-dependent, APOL4: apolipoprotein L, 4, 
MTP18: mitochondrial protein 18 kDa, CYTL1: cytokine-like 1, PHG-
DH: phosphoglycerate dehydrogenase, PSAT1: phosphoserine ami-
notransferase 1, IGSF4: cell adhesion molecule 1, IL6: interleukin 6 
(interferon, beta 2), NEBL: nebulette, FBN2: fibrillin 2, TAC1: tachyki-
nin, precursor 1, CXCL12: chemokine (C-X-C motif) ligand 12, SL-
C16A4: solute carrier family 16, member 4 (monocarboxylic acid 
transporter 5), ALDH1A3: aldehyde dehydrogenase 1 family, mem-
ber A3.Journal of Periodontal
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Table 2.  Genes up-/down-regulated on day 7 in osteogenic medium (over a 3-fold change).
RefSeq transcript Gene symbol Gene title Ratio
Up-regulated genes Day 7
Signal transduction
NM_000230 LEP Leptin (obesity homolog, mouse) 6.23 
NM_005052 RAC3 Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) 5.88 
NM_001003683 PDE1A Phosphodiesterase 1A, calmodulin-dependent 5.74 
NM_012334 MYO10 Myosin X 4.50 
NM_000384 APOB Apolipoprotein B (including Ag(x) antigen) 4.32 
NM_020134 DPYSL5 Dihydropyrimidinase-like 5 4.06 
NM_170776 GPR97 G protein-coupled receptor 97 4.04 
NM_052847 GNG7 Guanine nucleotide binding protein (G protein), gamma 7 3.84 
NM_004327 BCR Breakpoint cluster region 3.70 
NM_001627 ALCAM Activated leukocyte cell adhesion molecule 3.67 
NM_013385 PSCD4 Pleckstrin homology, Sec7 and coiled-coil domains 4 3.66 
NM_152573 RASEF RAS and EF-hand domain containing 3.13 
NM_023940 RASL11B RAS-like, family 11, member B 3.02 
Transport
NM_001442 FABP4 Fatty acid binding protein 4, adipocyte 7.19 
NM_024636 STEAP4 STEAP family member 4 5.49 
NM_001647 APOD Apolipoprotein D 5.10 
NM_030643 APOL4 Apolipoprotein L, 4 4.68 
NM_000384 APOB Apolipoprotein B (including Ag(x) antigen) 4.32 
NM_000084 CLCN5 Chloride channel 5 (nephrolithiasis 2, X-linked, dent disease) 4.30 
NM_000410 HFE Hemochromatosis 4.10 
NM_001008539 SLC7A2 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 3.79 
NM_000240 MAOA Monoamine oxidase A 3.76 
NM_020689 SLC24A3 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 3.50 
NM_014989 RIMS1 Regulating synaptic membrane exocytosis 1 3.40 
NM_022340 ZFYVE20 Zinc finger, FYVE domain containing 20 3.23 
NM_152573 RASEF RAS and EF-hand domain containing 3.13 
NM_004823 KCNK6 Potassium channel, subfamily K, member 6 3.12 
NM_017460 CYP3A4 Cytochrome P450, family 3, subfamily A, polypeptide 4 3.05 
Metabolism
NM_006587 CORIN Corin, serine peptidase 6.37 
NM_000230 LEP Leptin (obesity homolog, mouse) 6.23 
NM_004121 GGTLA1 Gamma-glutamyltransferase-like activity 1 5.34 
NM_001647 APOD Apolipoprotein D 5.10 
NM_030643 APOL4 Apolipoprotein L, 4 4.68 
NM_001966 EHHADH Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase 4.50 
NM_000384 APOB Apolipoprotein B (including Ag(x) antigen) 4.32 
NM_001008539 SLC7A2 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 3.79 
NM_000240 MAOA Monoamine oxidase A 3.76 
NM_015227 POFUT2 Protein O-fucosyltransferase 2 3.70 
NM_005957 MTHFR 5,10-methylenetetrahydrofolate reductase (NADPH) 3.50 
NM_014989 RIMS1 Regulating synaptic membrane exocytosis 1 3.40 
NM_005391 PDK3 Pyruvate dehydrogenase kinase, isozyme 3 3.32 
NM_001005502 CPM Carboxypeptidase M 3.14 
NM_000431 MVK Mevalonate kinase (mevalonicaciduria) 3.10 
NM_017460 CYP3A4 Cytochrome P450, family 3, subfamily A, polypeptide 4 3.05 
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RefSeq transcript Gene symbol Gene title Ratio
Cell adhesion
NM_000331 SAA1 Serum amyloid A1;serum amyloid A2 8.55 
NM_020403 PCDH9 Protocadherin 9 5.45 
NM_000095 COMP Cartilage oligomeric matrix protein 4.47 
NM_003872 NRP2 Neuropilin 2 3.93 
NM_001627 ALCAM Activated leukocyte cell adhesion molecule 3.67 
NM_003637 ITGA10 Integrin, alpha 10 3.40 
Apoptosis related
NM_001018011 PLZF Zinc finger and BTB domain containing 16 9.44 
NM_001003704 MTP18 Mitochondrial protein 18 kda 3.03 
Development
NM_001018011 PLZF Zinc finger and BTB domain containing 16 9.44 
NM_001031853 INSC Inscuteable homolog (Drosophila) 4.92 
NM_001001994 GPM6B Glycoprotein M6B 4.57 
NM_000095 COMP Cartilage oligomeric matrix protein 4.47 
NM_005251 FOXC2 Forkhead box C2 (MFH-1, mesenchyme forkhead 1) 4.11 
NM_003872 NRP2 Neuropilin 2 3.93 
NM_016848 SHC3 SHC (Src homology 2 domain containing) transforming protein 3 3.85 
NM_005667 RNF103 Ring finger protein 103 3.80 
NM_032495 HOP Homeodomain-only protein 3.72 
NM_004427 PHC2 Polyhomeotic homolog 2 (Drosophila) 3.67 
NM_001007156 NTRK3 Neurotrophic tyrosine kinase, receptor, type 3 3.33 
Cell-cell signaling
NM_000230 LEP Leptin (obesity homolog, mouse) 6.23 
Angiogenesis
NM_005251 FOXC2 Forkhead box C2 (MFH-1, mesenchyme forkhead 1) 4.11 
NM_003872 NRP2 Neuropilin 2 3.93 
Down-regulated genes
Signal transduction
NM_002462 MX1 Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) -3.84 
NM_018659 CYTL1 Cytokine-like 1 -3.51 
NM_000600 IL6 Interleukin 6 (interferon, beta 2) -3.35 
NM_003881 WISP2 WNT1 inducible signaling pathway protein 2 -3.10 
Transport
NM_002522 NPTX1 Neuronal pentraxin I -3.95 
NM_006623 PHGDH Phosphoglycerate dehydrogenase -3.43 
NM_003486 SLC7A5 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 -3.39 
Metabolism
NM_000963 PTGS2 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) -4.02 
NM_021154 PSAT1 Phosphoserine aminotransferase 1 -3.81 
NM_006623 PHGDH Phosphoglycerate dehydrogenase -3.43 
NM_003486 SLC7A5 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 -3.39 
NM_001673 ASNS Asparagine synthetase -3.29 
Cell adhesion
NM_001078 VCAM1 Vascular cell adhesion molecule 1 -3.88 
NM_014333 IGSF4 Immunoglobulin superfamily, member 4 -3.55 
NM_021101 CLDN1 Claudin 1 -3.34 
NM_003881 WISP2 WNT1 inducible signaling pathway protein 2 -3.10 
(Continued to the next page)
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RefSeq transcript Gene symbol Gene title Ratio
Apoptosis related
NM_002462 MX1 Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) -3.84 
NM_000600 IL6 Interleukin 6 (interferon, beta 2) -3.35 
Development
NM_002522 NPTX1 Neuronal pentraxin I -3.95 
NM_006623 PHGDH Phosphoglycerate dehydrogenase -3.43 
NM_002402 MEST Mesoderm specific transcript homolog (mouse) -3.09 
Cell-cell signaling
NM_000600 IL6 Interleukin 6 (interferon, beta 2) -3.35 
NM_003881 WISP2 WNT1 inducible signaling pathway protein 2 -3.10 
Table 3.  Genes up-/down-regulated on day 14 in osteogenic medium (over a 3-fold change).
RefSeq transcript Gene symbol Gene title Ratio
Up-regulated genes Day 14
Signal transduction
NM_000230 LEP Leptin (obesity homolog, mouse) 7.68 
NM_005052 RAC3 Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) 3.41 
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95 
NM_005233 EPHA3 EPH receptor A3 5.40 
NM_033315 RASL10B RAS-like, family 10, member B 4.66 
NM_000856 GUCY1A3 Guanylatecyclase 1, soluble, alpha 3 4.25 
NM_023940 RASL11B RAS-like, family 11, member B 3.96 
NM_000679 ADRA1B Adrenergic, alpha-1B-, receptor 3.77 
NM_001025300 RAB12 RAB12, member RAS oncogene family 3.57 
NM_025113 C13orf18 Chromosome 13 open reading frame 18 3.09 
Transport
NM_024636 STEAP4 STEAP family member 4 6.22 
NM_001008539 SLC7A2 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 5.84 
NM_001442 FABP4 Fatty acid binding protein 4, adipocyte 5.66 
NM_006393 NEBL Nebulette 5.26 
NM_012429 SEC14L2 SEC14-like 2 (S. Cerevisiae) 4.84 
NM_001647 APOD Apolipoprotein D 4.70 
NM_000240 MAOA Monoamine oxidase A 4.30 
NM_053277 CLIC6 Chloride intracellular channel 6 3.97 
NM_001025300 RAB12 RAB12, member RAS oncogene family 3.57 
NM_014989 RIMS1 Regulating synaptic membrane exocytosis 1 3.13 
NM_001034954 SORBS1 Sorbin and SH3 domain containing 1 3.10 
Metabolism
NM_000230 LEP Leptin (obesity homolog, mouse) 7.68 
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95 
NM_002612 PDK4 Pyruvate dehydrogenase kinase, isozyme 4 6.78 
NM_001008539 SLC7A2 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 5.84 
NM_006587 CORIN Corin, serine peptidase 5.06 
NM_000240 MAOA Monoamine oxidase A 5.03 
NM_006433 GNLY Granulysin 4.92 
NM_001647 APOD Apolipoprotein D 4.70 
NM_004121 GGTLA1 Gamma-glutamyltransferase-like activity 1 4.29 
NM_014989 RIMS1 Regulating synaptic membrane exocytosis 1 3.13 
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RefSeq transcript Gene symbol Gene title Ratio
NM_178543 ENPP7 Ectonucleotidepyrophosphatase/phosphodiesterase 7 3.32 
NM_017882 CLN6 Ceroid-lipofuscinosis, neuronal 6, late infantile, variant 3.27 
NM_002423 MMP7 Matrix metallopeptidase 7 (matrilysin, uterine) 3.21 
Cell adhesion
NM_000331 SAA1 Serum amyloid A1;serum amyloid A2 7.40 
NM_000095 COMP Cartilage oligomeric matrix protein 4.15
NM_001999 FBN2 Fibrillin 2 (congenital contracturalarachnodactyly) 3.43 
NM_003637 ITGA10 Integrin, alpha 10 3.35 
NM_007183 PKP3 Plakophilin 3 3.23 
Apoptosis related
NM_001018011 PLZF Zinc finger and BTB domain containing 16 10.22 
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95 
NM_002015 FOXO1A Forkhead box O1A (rhabdomyosarcoma) 4.89 
NM_012429 SEC14L2 SEC14-like 2 (S. Cerevisiae) 4.84 
Development
NM_001018011 PLZF Zinc finger and BTB domain containing 16 10.22 
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95 
NM_001031853 INSC Inscuteable homolog (Drosophila) 6.11 
NM_002015 FOXO1A Forkhead box O1A (rhabdomyosarcoma) 4.89 
NM_001001994 GPM6B Glycoprotein M6B 4.49 
NM_000095 COMP Cartilage oligomeric matrix protein 4.15
NM_005251 FOXC2 Forkhead box C2 (MFH-1, mesenchyme forkhead 1) 4.00 
NM_002347 LY6H Lymphocyte antigen 6 complex, locus H 3.91 
NM_000679 ADRA1B Adrenergic, alpha-1B-, receptor 3.77 
NM_001463 FRZB Frizzled-related protein 3.45 
NM_002110 HCK Hemopoietic cell kinase 3.27 
NM_006291 TNFAIP2 Tumor necrosis factor, alpha-induced protein 2 3.12 
Cell-cell signaling
NM_000230 LEP Leptin (obesity homolog, mouse) 7.68 
NM_003182 TAC1 Tachykinin, precursor 1 (substance K, substance P, neurokinin 1, neurokinin 2, neuromedin L, 
neurokinin alpha, neuropeptide K, neuropeptide gamma)
4.66 
NM_000679 ADRA1B Adrenergic, alpha-1B-, receptor 3.77 
Angiogenesis
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95 
NM_005251 FOXC2 Forkhead box C2 (MFH-1, mesenchyme forkhead 1) 4.00 
NM_006291 TNFAIP2 Tumor necrosis factor, alpha-induced protein 2 3.12 
Down-regulated genes
Signal transduction
NM_002462 MX1 Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) -3.28 
NM_000609 CXCL12 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) -3.19 
NM_005623 CCL8 Chemokine (C-C motif) ligand 8 -3.08 
NM_001018056 VLDLR Very low density lipoprotein receptor -3.07 
NM_003881 WISP2 WNT1 inducible signaling pathway protein 2 -3.06 
Transport
NM_002522 NPTX1 Neuronal pentraxin I -4.30 
NM_004696 SLC16A4 Solute carrier family 16, member 4 (monocarboxylic acid transporter 5) -3.32 
NM_005623 CCL8 Chemokine (C-C motif) ligand 8 -3.08 
NM_001018056 VLDLR Very low density lipoprotein receptor -3.07 
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RefSeq transcript Gene symbol Gene title Ratio
Metabolism
NM_000963 PTGS2 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) -4.25 
NM_000693 ALDH1A3 Aldehyde dehydrogenase 1 family, member A3 -3.11 
NM_001018056 VLDLR Very low density lipoprotein receptor -3.07 
Cell adhesion
NM_001078 VCAM1 Vascular cell adhesion molecule 1 -4.30 
NM_021101 CLDN1 Claudin 1 -3.67 
NM_000609 CXCL12 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) -3.19 
NM_003881 WISP2 WNT1 inducible signaling pathway protein 2 -3.06 
Apoptosis related
NM_002462 MX1 Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) -3.28 
NM_000693 ALDH1A3 Aldehyde dehydrogenase 1 family, member A3 -3.11 
Development
NM_002522 NPTX1 Neuronal pentraxin I -4.30 
NM_002402 MEST Mesoderm specific transcript homolog (mouse) -3.67 
NM_000693 ALDH1A3 Aldehyde dehydrogenase 1 family, member A3 -3.11 
NM_001018056 VLDLR Very low density lipoprotein receptor -3.07 
Cell-cell signaling
NM_000609 CXCL12 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) -3.19 
NM_005623 CCL8 Chemokine (C-C motif) ligand 8 -3.08 
NM_003881 WISP2 WNT1 inducible signaling pathway protein 2 -3.06 
Table 4.  Genes more highly up-/down-regulated on day 7 than on day 14 in osteogenic medium.
RefSeq transcript Gene symbol Gene title Ratio
Up-regulated genes Day 7 Day 14
Signal transduction
NM_001003683 PDE1A Phosphodiesterase 1A, calmodulin-dependent 5.74  1.90
NM_000384 APOB Apolipoprotein B (including Ag(x) antigen) 4.32  2.42
NM_013385 PSCD4 Pleckstrin homology, Sec7 and coiled-coil domains 4 3.66  2.75
Transport
NM_000384 APOB Apolipoprotein B (including Ag(x) antigen) 4.32  2.42
NM_000410 HFE Hemochromatosis 4.10  1.37
NM_020689 SLC24A3 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 3.50  3.12
NM_004823 KCNK6 Potassium channel, subfamily K, member 6 3.12  2.59
Metabolism
NM_000384 APOB Apolipoprotein B (including Ag(x) antigen) 4.32  2.42
NM_001005502 CPM Carboxypeptidase M 3.14  2.41
NM_000431 MVK Mevalonate kinase (mevalonicaciduria) 3.10  2.07
Cell adhesion
NM_020403 PCDH9 Protocadherin 9 5.45  2.35
NM_003872 NRP2 Neuropilin 2 3.93  1.18
Development
NM_003872 NRP2 Neuropilin 2 3.93  1.18
NM_016848 SHC3 SHC (Src homology 2 domain containing) transforming protein 3 3.85  2.84
Angiogenesis
NM_003872 NRP2 Neuropilin 2 3.93  1.18
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Table 5.  Genes more highly up-/down-regulated on day 14 than on day 7 in osteogenic medium.
RefSeq transcript Gene symbol Gene title Ratio
Up-regulated genes Day 14 Day 7
Signal transduction
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95  1.10
NM_005233 EPHA3 EPH receptor A3 5.40  2.79
NM_001025300 RAB12 RAB12, member RAS oncogene family 3.57  1.02
Transport
NM_006393 NEBL Nebulette 5.26  3.24
NM_012429 SEC14L2 SEC14-like 2 (S. Cerevisiae) 4.84  1.82
NM_053277 CLIC6 Chloride intracellular channel 6 3.97  1.77
NM_001025300 RAB12 RAB12, member RAS oncogene family 3.57  1.02
Metabolism
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95  1.10
NM_002612 PDK4 Pyruvate dehydrogenase kinase, isozyme 4 6.78  1.95
NM_006433 GNLY Granulysin 4.92  1.61
Cell adhesion
NM_001999 FBN2 Fibrillin 2 (congenital contracturalarachnodactyly) 3.43  2.68
Apoptosis related
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95  1.10
NM_002015 FOXO1A Forkhead box O1A (rhabdomyosarcoma) 4.89  1.18
NM_012429 SEC14L2 SEC14-like 2 (S. Cerevisiae) 4.84  1.82
Development
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95  1.10
NM_002015 FOXO1A Forkhead box O1A (rhabdomyosarcoma) 4.89  1.18
NM_001463 FRZB Frizzled-related protein 3.45  2.74
NM_002110 HCK Hemopoietic cell kinase 3.27  2.00
(Continued to the next page)
RefSeq transcript Gene symbol Gene title Ratio
Down-regulated genes Day 7 Day 14
Signal transduction
NM_018659 CYTL1 Cytokine-like 1 -3.51  -2.76
NM_000600 IL6 Interleukin 6 (interferon, beta 2) -3.35  -2.91
Transport
NM_006623 PHGDH Phosphoglycerate dehydrogenase -3.43  -1.66
NM_003486 SLC7A5 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 -3.39  -2.88
Metabolism
NM_021154 PSAT1 Phosphoserine aminotransferase 1 -3.81  -1.91
NM_006623 PHGDH Phosphoglycerate dehydrogenase -3.43  -1.66
NM_003486 SLC7A5 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 -3.39  -2.88
NM_001673 ASNS Asparagine synthetase -3.29  -1.54
Cell adhesion
NM_014333 IGSF4 Immunoglobulin superfamily, member 4 -3.55  -2.49
Apoptosis related
NM_000600 IL6 Interleukin 6 (interferon, beta 2) -3.35  -2.91
Development
NM_006623 PHGDH Phosphoglycerate dehydrogenase -3.43  -1.66
Cell-cell signaling
NM_000600 IL6 Interleukin 6 (interferon, beta 2) -3.35  -2.91
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RefSeq transcript Gene symbol Gene title Ratio
Cell-cell signaling
NM_003182 TAC1 Tachykinin, precursor 1 (substance K, substance P, neurokinin 1, neurokinin 2, 
neuromedin L, neurokinin alpha, neuropeptide K, neuropeptide gamma)
4.66  2.05
NM_000679 ADRA1B Adrenergic, alpha-1B-, receptor 3.77  2.74
Angiogenesis
NM_001039667 ANGPTL4 Angiopoietin-like 4 6.95  1.10
Down-regulated genes
Signal transduction
NM_000609 CXCL12 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) -3.19  -2.67
NM_005623 CCL8 Chemokine (C-C motif) ligand 8 -3.08  -2.41
Transport
NM_004696 SLC16A4 Solute carrier family 16, member 4 (monocarboxylic acid transporter 5) -3.32  -1.64
NM_005623 CCL8 Chemokine (C-C motif) ligand 8 -3.08  -2.41
Metabolism
NM_000693 ALDH1A3 Aldehyde dehydrogenase 1 family, member A3 -3.11  -2.22
Cell adhesion
NM_000609 CXCL12 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) -3.19  -2.67
Apoptosis related
NM_000693 ALDH1A3 Aldehyde dehydrogenase 1 family, member A3 -3.11  -2.22
Development
NM_000693 ALDH1A3 Aldehyde dehydrogenase 1 family, member A3 -3.11  -2.22
Cell-cell signaling
NM_000609 CXCL12 Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) -3.19  -2.67
NM_005623 CCL8 Chemokine (C-C motif) ligand 8 -3.08  -2.41
and PKP3, and the down-regulated gene was CXCL12. Of 
those related to cell adhesion on both days, the up-regulated 
genes were SAA1, COMP4, and ITGA10, and the down-regu-
lated genes were VCAM1, CLDN1, and WISP2. Interestingly, 
up- and down-regulated genes such as PCDH9, NRP2, AL-
CAM, and IGSF4 were more strongly expressed on day 7 than 
day 14, while FBN2 and CXCL12 were more strongly expressed 
on day 14 than on day 7. 
Genes related to apoptosis
On day 7, the up-regulated gene related to apoptosis was 
MTP18, and the down-regulated gene was IL6. On day 14, up-
regulated genes were ANGPTL4, FOXO1A and SEC14L2, while 
the down-regulated gene was ALDH1A3. For both days, the 
up-regulated gene was PLZF, and the down-regulated gene 
was MX1. Notably, the up- and down-regulated gene IL6 was 
more strongly expressed on day 7 than on day 14, while ANG-
PTL4, FOXO1A, SEC14L2 and ALDH1A3 were more strongly 
expressed on day 14 than on day 7.
Genes related to development
On day 7, the up-regulated genes related to development 
were NRP2, SHC3, RNF103, etc., and the down-regulated gene 
was PHGDH. On day 14, the up-regulated genes were ANG-
PTL4, FOXO1A, LY6H, etc., and the down-regulated gene was 
ALDH1A3. For both days, up-regulated genes were PLZF, INS, 
GPM6B, COMP4, and FOXC2, and the down-regulated genes 
were NPTX1 and MEST. Notably, up- and down-regulated 
genes NRP2, SHC3, PHC2, and PHGDH were more strongly 
expressed on day 7 than on day 14, and ANGPTL4, FOXO1A, 
FRZB, and HCK were more strongly expressed on day 14 than 
on day 7.
Genes related to cell-cell signaling
On day 7, no up-regulated genes related to cell-cell signal-
ing were observed, while the down-regulated gene was IL6. 
On day 14, the up-regulated genes were TAC1 and ADRA1B, 
and the down-regulated genes were CXCL12 and CCL8. For 
both days, up-regulated gene was LEP, and the down-regu-
lated gene was WISP2. Interestingly, up- and down-regulated 
genes the gene IL6 was more strongly expressed on day 7 than 
on day 14, and TAC1, ADRA1B, CXCL12, and CCL8 were strong-
ly expressed on day 14 than on day 7.
Genes related to angiogenesis
On day 7, the up-regulated gene related to angiogenesis 
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was NRP2. On day 14, the up-regulated genes were ANGPTL4 
and TNFAIP2. For both days, the up-regulated gene was 
FOXC2. However, on the indicated day, genes related to an-
giogenesis were not observed among the down-regulated 
genes. Nevertheless, up- and down-regulated genes the gene 
NRP2 was more strongly expressed on day 7 than on day 14, 
and ANGPTL4 was more strongly expressed on day 14 than 
on day 7.
DISCUSSION
PDL cells have been known as multipotential cells, so they 
have a capacity to differentiate into osteoblasts, cemento-
blasts, adipocytes, and collagen-forming cells. Several previ-
ous studies [5,13,14] have reported that because of the stem 
cells in the PDL, the PDL has a regenerative capacity to re-
store connective tissues and mineralized tissues when ap-
propriately triggered. PDL cells have been reported to form 
mineralized nodules in vitro [5,15,16]. Osteoblasts form bone-
like mineralized nodules by undergoing three stages of dif-
ferentiation: proliferation, extracellular matrix maturation 
and mineralization. Actually, the stage of matrix maturation 
is around day 7, and the early stage of mineralization or late 
stage of matrix maturation is around day 14. Therefore the 
difference in gene expression in the cells cultured on days 7 
and 14 was analyzed.
DNA microarray analysis of the cells cultured on days 7 and 
14 under the osteogenic or non-osteogenic medium, was 
performed. The genes which were expressed in hPDL cells 
were classified by function. Each group was divided into the 
functions of signal transduction, transport, metabolism, cell 
adhesion, apoptosis, development, cell-cell signaling, and 
angiogenesis. To validate the DNA microarray data, some 
genes expressed at each function’s groups on the indicated 
days were selected. The 12 out of 14 genes were comparable 
with DNA microarray data. Therefore, it was thought that the 
DNA microarray analysis is a reliable method for examining 
a gene expression profile.
It was considered that up or down regulated genes that were 
expressed more or less on day 7 than on day 14 were more 
important and related to each stage of differentiation of hPDL 
cells than other genes. Thus, focus was directed toward the 
genes which showed differences greater than 2-fold between 
day 7 and day 14. 
On day 7, PDE1A, PSCD4, APOB, HFE, SLC24A3, KCNK6, 
CPM, MVK, PCDH9, NRP2, and SHC3 were more strongly 
up-regulated than on day 14 in osteogenic medium. The 
functions of these genes are related to calcium/iron/metal 
ion binding or homeostasis (PDE1A, HFE, SLC24A3, KCNK6, 
CPM, and PCDH9), cholesterol synthesis or homeostasis 
(APOB and MVK) and cell survival, migration, and invasion 
(NRP2). Genes PDE1A, HFE, PCDH9, and NRP2 were shown 
to have more than a 2-fold difference between day 7 and 14.
As members of the PDE1 family, PDE1A (phosphodiesterase 
1A, calmodulin-dependent) is a Ca
(2+)/calmodulin dependent 
PDEs that is activated by calmodulin in the presence of Ca
(2+) 
[17,18]. It was reported that calmodulin regulates osteoblast 
differentiation [19]. Therefore, PDE1A is related to calmodu-
lin binding, signal transduction and ion binding.
The protein encoded by HFE is a membrane protein that is 
similar to MHC class I-type proteins and associates with β2-
microglobulin (β2M). It is thought that the protein encoded 
by HFE functions to regulate iron absorption by regulating 
the interaction of the transferrin receptor with transferrin. 
PCDH9 (protocadherin 9) belongs to the protocadherin 
gene family, a subfamily of the cadherin superfamily. Cad-
herins are a superfamily of calcium-dependent adhesion mol-
ecules that play multiple roles in morphogenesis, including 
proliferation, migration, differentiation and cell-cell recogni-
tion [20]. It is thought that PCDH9 is related to calcium ion 
binding, protein binding and cell adhesion.
NRP2 (neuropilin 2) encodes a member of the neuropilin 
family of receptor proteins. NRP2 is related to protein bind-
ing, cell adhesion, cell differentiation, neural crest cell migra-
tion, and heart/nervous system/multicellular organismal de-
velopment. Some studies have reported that NRP2 expression 
enhances cell survival, migration, and invasion [21].
Thus these findings suggested that related genes during 
the stage of matrix maturation of hPDL cells cultured in os-
teogenic medium were associated with calcium/iron/metal 
ion binding or homeostasis, and cell viability.
On day 14, ANGPTL4, EPHA3, RAB12, NEBL, SEC14L2, CLIC6, 
PDK4, GNLY, FBN2, FOXO1A, FRZB, HCK, TAC1, and ADRA1B 
were more strongly up-regulated than on day 7 in osteogenic 
medium. The functions of these genes are related to apopto-
sis and angiogenesis (ANGPTL4 and FOXO1A), adipogenesis 
(ANGPTL4, SEC14L2, and PDK4), calcium-binding or ion 
channel activity (FBN2 and CLIC6), migration (HCK and 
ADRA1B), and Wnt antagonist and regulation of bone devel-
opment (FRZB). Interestingly, the genes ANGPTL4, SEC14L2, 
PDK4, and FOXO1A were shown to have more than a 2-fold 
difference between day 7 and day 14. 
ANGPTL4 (angiopoietin-like 4) is a member of the angio-
poietin/angiopoietin-like gene family and encodes a glyco-
sylated, secreted protein with a fibrinogen C-terminal do-
main. Hopwood et al. [22] reported that adipogenesis and 
lipid and/or glucose metabolism related gene, ANGPTL4, was 
expressed in fractured human bone. Also, this gene was re-
lated to cell differentiation, multicellular organismal devel-
opment, negative regulation of apoptosis, positive regulation Journal of Periodontal
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of angiogenesis, and signal transduction. 
SEC14L2 (SEC14-like 2) encodes a cytosolic protein that be-
longs to a family of lipid-binding proteins including Sec14p, 
alpha-tocopherol transfer protein, and cellular retinol-bind-
ing protein. SEC14L2 was related to phospholipid binding, vi-
tamin E binding and cholesterol synthesis.
FOXO1A (forkhead box O1) belongs to the forkhead family 
of transcription factors, which are characterized by a distinct 
forkhead domain. FOXO1A was related to anti-apoptosis, 
blood vessel development, and regulation of cell prolifera-
tion.
Thus, these findings suggested that related genes during 
the early stage of mineralization or the late stage of matrix 
maturation by hPDL cells cultured in osteogenic medium 
were more associated with apoptosis, angiogenesis, and adi-
pogenesis.
CYTL1, IL6, PHGDH, SLC7A5, PSAT1, ASNS, and IGSF4 were 
more strongly up-regulated genes on day 7 than on day 14 in 
non-osteogenic medium. The functions of these genes were 
related to proliferation (CYTL1, PHGDH, PSAT1, SLC7A5, and 
IGSF4) and inflammation (CYTL1 and IL6). In particular, the 
genes PHGDH and PSAT1 were shown to have more than a 
2-fold difference between day 7 and day 14 . 
PHGDH (phosphoglycerate dehydrogenase) is related to 
processes such as cell cycle process and cell development. 
Cho et al. [23] reported that the human PHGDH gene is regu-
lated at the transcriptional level in a tissue and is dependent 
on the cellular proliferation status. Pollari et al. [24] reported 
that L-serine biosynthesis genes such as PHGDH and PSAT1 
stimulate osteoclastogenesis and cancer cell proliferation. 
Thus, these genes were related to proliferation. 
Thus, these findings suggested that related genes during 
the stage of matrix maturation of hPDL cells cultured in non-
osteogenic medium were more associated with proliferation. 
On day 14, CXCL12, CCL8, SLC16A4, and ALDH1A3 were 
more strongly up-regulated genes than on day 7 in non-os-
teogenic medium. The functions of these genes were related 
to inflammation or the immune response (CXCL12 and CCL8), 
detoxification (ALDH1A3), and cell migration (SLC16A4). No-
tably, a gene like SLC16A4 showed a difference more than 
2-fold between day 7 and day 14 . 
SLC16A4 (solute carrier family 16, member 4 [monocarbox-
ylic acid transporter 5]) is a member of the SLC16 family of 
solute transporters. Gallagher et al. [25] reported that the spe-
cific interaction of SLC16A4 with β1 integrin may regulate 
cell migration.
Thus, these findings suggested that related genes during 
the early stage of mineralization or the late stage of matrix 
maturation by hPDL cells cultured in non-osteogenic medi-
um were more associated with cell migration.
Based on these results, it is suggested that several genes re-
lated to proliferation or migration were expressed when hPDL 
cells were cultured in non-osteogenic medium. Also, expres-
sion of the genes related to calcium/iron/metal ion binding 
or homeostasis and cell viability were increased at the stage 
of matrix maturation, and expression of the genes related to 
apoptosis, angiogenesis, and adipogenesis were increased at 
the early stage of mineralization or the late stage of matrix 
maturation when hPDL cells were cultured in osteogenic 
medium.
In conclusion, this study suggests that when appropriately 
triggered, the stem cells in the hPDL differentiate into osteo-
blasts/cementoblasts, and, the genes related to calcium bind-
ing such as PDE1A, PCDH9, which was strongly expressed at 
the stage of matrix maturation, may be associated with dif-
ferentiation of the hPDL cells into osteoblasts/cementoblasts. 
Further studies are needed to examine the precise function 
of these genes.
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